UBS AM
AHCO icon

UBS AM’s AdaptHealth AHCO Stock Holding History

UBS AM’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
211,807
-6,427
-3% -$71.8K ﹤0.01% 2006
2026
Q1 		$2.6M Sell
218,234
-4
-0% -$41 ﹤0.01% 1915
2025
Q4 		$2.17M Buy
218,238
+3,919
+2% +$37.4K ﹤0.01% 1854
2025
Q3 		$1.92M Sell
214,319
-147,244
-41% -$1.36M ﹤0.01% 1774
2025
Q2 		$3.41M Buy
361,563
+127,783
+55% +$1.13M ﹤0.01% 1893
2025
Q1 		$2.53M Buy
233,780
+35,879
+18% +$361K ﹤0.01% 1881
2024
Q4 		$1.88M Buy
197,901
+35,431
+22% +$359K ﹤0.01% 2078
2024
Q3 		$1.82M Buy
162,470
+11,757
+8% +$125K ﹤0.01% 2080
2024
Q2 		$1.51M Buy
150,713
+84,206
+127% +$856K ﹤0.01% 2147
2024
Q1 		$765K Buy
66,507
+3,444
+5% +$29.3K ﹤0.01% 2144
2023
Q4 		$460K Hold
63,063
– – ﹤0.01% 2342
2023
Q3 		$574K Buy
63,063
+10,031
+19% +$120K ﹤0.01% 2240
2023
Q2 		$659K Hold
53,032
– – ﹤0.01% 2209
2023
Q1 		$659K Sell
53,032
-18,842
-26% -$347K ﹤0.01% 2209
2022
Q4 		$1.38M Buy
71,874
+3,737
+5% +$79K ﹤0.01% 1701
2022
Q3 		$1.28M Sell
68,137
-148,522
-69% -$3.05M ﹤0.01% 1824
2022
Q2 		$3.91M Sell
216,659
-78,011
-26% -$1.27M ﹤0.01% 1305
2022
Q1 		$4.72M Buy
294,670
+198,808
+207% +$3.57M ﹤0.01% 1380
2021
Q4 		$2.34M Buy
95,862
+16,299
+20% +$383K ﹤0.01% 1792
2021
Q3 		$1.85M Buy
79,563
+3,758
+5% +$90.9K ﹤0.01% 1873
2021
Q2 		$2.08M Buy
+75,805
New +$2.16M ﹤0.01% 1831

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM's AHCO Position: Q2 2026 in Review

UBS AM reduced its AdaptHealth (AHCO) stake by 2.9% in Q2 2026, selling an estimated $71.8K and leaving 211,807 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

UBS AM first reported a position in AHCO in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.72M in Q1 2022. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • UBS AM held 211,807 shares of AdaptHealth worth $2.21M as of Q2 2026.
  • UBS AM sold 6,427 AdaptHealth shares in Q2 2026, an estimated $71.8K.
  • AdaptHealth made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2006 holding.
  • UBS AM first reported a position in AdaptHealth in Q2 2021 and has held it in 21 quarters since.
  • UBS AM's AdaptHealth position peaked at $4.72M in Q1 2022.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.